Navigation Links
Inspiration Biopharmaceuticals' OBI-1 Receives Orphan Drug Designation in Europe
Date:10/19/2010

LAGUNA NIGUEL, Calif., Oct. 19 /PRNewswire/ -- Inspiration Biopharmaceuticals, Inc. (Inspiration) announced today that the European Commission has granted orphan drug status for OBI-1 for the treatment of hemophilia.  Expected to enter pivotal clinical trials before the end of this year, OBI-1 is designed to treat individuals with hemophilia who have developed inhibitors against human Factor VIII (hFVIII).  The orphan drug status would trigger a 10-year market exclusivity for OBI-1 in the European Union after its marketing approval.  The U.S. Food & Drug Administration (FDA) issued an Orphan Drug Designation for OBI-1 in March 2004.

Michael Griffith, Ph.D., President and CEO of Inspiration, commented, "OBI-1 provides a unique, alternative approach to treating individuals with hemophilia who develop an immune reaction to human FVIII.  The orphan drug designation in Europe is another sign of the overall progress of our program to develop OBI-1 and address a clear, unmet medical need among individuals with hemophilia."  According to a partnership agreement signed with Ipsen SA (Euronext: IPN; ADR: IPSEY) in January 2010, Inspiration licensed OBI-1 from Ipsen and is responsible for the OBI-1 clinical trial development and commercialization.

About Hemophilia

Hemophilia is a bleeding disorder caused by low levels or absence of a protein called a coagulation factor, essential for blood clotting.  The two most common forms of hemophilia are types A and B.  Hemophilia A is caused by a factor VIII deficiency and occurs in ~1 out of every 5,000 male births.  Hemophilia B is caused by factor IX deficiency and occurs in ~1 out of every 30,000 male births.  Approximately 60% of persons with hemophilia have a severe condition, which results in frequent spontaneous bleeding episodes in addition to serious bleeding after injuries.  The annual market for hemophilia treatments is $7.5 billion worldwid
'/>"/>

SOURCE Inspiration Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. National Expressions of Courage Art Contest Unveils Stories of Inspiration
2. Inspiration for My Sisters Keeper Speaks Out
3. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
4. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
5. Keryx Biopharmaceuticals to Present at BioCenturys NewsMakers in the Biotech Industry Conference
6. Keryx Biopharmaceuticals to Present at JMP Securities Healthcare Conference
7. FierceBiotech Designates Alder Biopharmaceuticals One of Top Private Biotechs, Member of the 2010 Fierce 15
8. Keryx Biopharmaceuticals to Present at the 22nd Annual ROTH OC Growth Stock Conference
9. Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
10. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
11. Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 Reportlinker.com ... available in its catalogue: North America ... http://www.reportlinker.com/p02343464/North-America-Laparoscopes-Market-Outlook-to-2020.html North America Laparoscopes ... new report, "North America Laparoscopes Market Outlook to ... America Laparoscopes market. The report provides value, in ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- EDGE ... device space, is excited to announce they have ... VIEW Plating System and REDUCE Fracture Plating System. ... plates used to support multiple indications within the ... Lapidus, First Metatarsophalangeal (MTP), Calcaneal-Cuboid (CC), Talonavicular (TN) ...
(Date:8/28/2014)... , Aug. 28, 2014  Decision Resources Group finds that ... at around $7.7 billion by 2023 in the ... Germany , Italy , ... and Japan . The biosimilar erosion ... be balanced out by the launch of Eli Lilly,s Cyramza, ...
Breaking Medicine Technology:North America Laparoscopes Market Outlook to 2020 2North America Laparoscopes Market Outlook to 2020 3North America Laparoscopes Market Outlook to 2020 4North America Laparoscopes Market Outlook to 2020 5North America Laparoscopes Market Outlook to 2020 6North America Laparoscopes Market Outlook to 2020 7North America Laparoscopes Market Outlook to 2020 8North America Laparoscopes Market Outlook to 2020 9North America Laparoscopes Market Outlook to 2020 10North America Laparoscopes Market Outlook to 2020 11EDGE Orthopaedics Receives Second FDA Clearance 2The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2
(Date:8/28/2014)... iFitDress.com, the distinguished wedding dress manufacturer and retailer, has ... . Included in the new range are hundreds of ... provided at deeply discounted prices, from 22 to 62 ... reliable delivery service. All clients from around the world ... As is commonly noted, international customers have different needs ...
(Date:8/28/2014)... Blood's Thicker Than Water is based on a ... in the heart of the city. Raymond E. Blake paints ... how disrespect caused two families to collide with each other ... Yayo Boyz and the M.O.B. Boyz clash in a rain ... in a silent terror. "Guerrilla," AKA "Real," runs his Mob ...
(Date:8/28/2014)... 28, 2014 Millennium Treatment Group has ... in the workplace. A recent report from the ... states that drug abuse is costing employers an estimated ... are addicted to drugs affect their employers and the ... into the workplace, causing expensive problems for their employers, ...
(Date:8/28/2014)... plans its exit strategy from the war, now may be ... health care to veterans, says a Perspective piece in the ... go on doing more of the same is to fail ... and population structure pose in the longer run," said William ... Practice, and David Auerbach, from the RAND Corporation, in the ...
(Date:8/28/2014)... 2014 The Governor of Yucatán, Rolando ... at a press conference; this event is organized by ... of Economy through the National Microenterprise Financing Program ( ... to the 5th at the Convention Center Yucatan Siglo ... a great responsibility for Yucatan to host the 17th ...
Breaking Medicine News(10 mins):Health News:New Selection of Chic Bridesmaid Dresses Available at iFitDress.com 2Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2Health News:Drug Use Causes Problems in the Workplace 2Health News:A VA exit strategy 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 3
... that early surgery for acute shoulder dislocation may provide ... approximately 45 million children and adolescents participate in organized ... Two types of shoulder injuries that occur in these ... care. According to a paper published in the February ...
... PASADENA, Calif., Feb. 2 Alexandria Real Estate Equities, Inc. ... conduct a conference call and audio web cast on Monday, ... conjunction with the release of its operating and financial results ... Alexandria anticipates releasing its operating and financial results before ...
... 2 Pet advocates are encouraging,pet owners to focus ... Pet,Dental Health Month this February. And it appears ... PetFirst Healthcare saw claims,for illnesses related to oral-health increase ... "Many pet owners don,t place as much emphasis ...
... gather for the Experimental Biology 2009 meeting at the ... 18 -April 22. , Experimental Biology,s mission is to ... future and current clinical advances and to give ... colleagues working on similar biomedical problems using different disciplines. ...
... Feb. 2 Availity, LLC, a leading ... MedEZ, a leading,provider of medical and behavioral ... health care claim transactions. Health care,providers with ... via the,Availity(R) Health Information Network. The partnership ...
... 2 WHAT: The new Health Workforce Information ... to the most recent resources on the nation,s ... shortages of physicians, nurses and allied health personnel ... help policy makers, hospitals and schools develop strategies ...
Cached Medicine News:Health News:Immediate Orthopaedic Care Can Help Heal a Young Athlete's Shoulder 2Health News:Immediate Orthopaedic Care Can Help Heal a Young Athlete's Shoulder 3Health News:Pet Dental Claims Skyrocket 2Health News:Experimental Biology 2009 meets April 18-22 2Health News:Experimental Biology 2009 meets April 18-22 3Health News:Experimental Biology 2009 meets April 18-22 4Health News:Experimental Biology 2009 meets April 18-22 5Health News:Availity Partners With MedEZ 2Health News:Press Conference Invitation: Health Workforce Information Center (HWIC) Launch 2
Angled insertion forcep used for the Hydroview lens. Manufactured in titanium....
Bi-angled insertion jaws designed to enhance surgeon comfort and efficiency. Reverse action releases lens when handle is compressed. Made in titanium....
Biconvex jaw design. 40 degree angled shafts. Tip to angle length: 7.5 mm. Locking handle. Manufacturing in titanium....
Titanium. Forceps designed for insertion of Hydroview foldable intraocular lenses. Unique cross-action design allows for easy insertion of most foldable lens styles....
Medicine Products: